Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	97.47	79.51	164.89	87.43	11.97
Short-Term Investments	326.68	446.73	285.61	211.94	16.3
Cash & Cash Equivalents	424.15	526.24	450.5	299.37	28.27
Cash Growth	-19.40%	16.81%	50.48%	958.99%	-8.91%
Receivables	51.13	52.75	138.91	183.86	6.56
Other Current Assets	32.56	48.89	22.55	40.39	2.26
Total Current Assets	507.85	627.87	611.96	523.62	37.08
Property, Plant & Equipment	83.46	81.35	62.29	40.2	8.61
Long-Term Investments	444.01	339.03	507.01	132.5	42.82
Goodwill and Intangibles	165.11	293.67	86.81	0	0
Other Long-Term Assets	34.9	44.12	10.65	4.14	0.25
Total Long-Term Assets	727.48	758.18	666.76	176.85	51.68
Total Assets	1,235	1,386	1,279	700.46	88.76
Accounts Payable	15.36	23.09	20.49	26.49	1.58
Deferred Revenue	2.87	3.2	14.57	26.58	0.37
Current Debt	1.18	20.64	21.28	15.02	0.42
Other Current Liabilities	53.6	41.18	48.96	62.03	1.36
Total Current Liabilities	73.02	88.11	105.31	130.12	3.72
Long-Term Debt	0	0	0	0	2.26
Other Long-Term Liabilities	29.02	28.07	7.53	0.96	0
Total Long-Term Liabilities	29.02	28.07	7.53	0.96	2.26
Total Liabilities	102.04	116.18	112.84	131.07	5.98
Total Debt	1.18	20.64	21.28	15.02	2.68
Debt Growth	-94.27%	-3.04%	41.71%	461.25%	-
Retained Earnings	633.18	801	657.6	150.88	-63.43
Comprehensive Income	1.21	-20.9	-0.76	0.44	0.15
Shareholders' Equity	1,136	1,267	1,159	569.39	82.78
Net Cash / Debt	422.97	505.6	429.22	284.35	25.59
Net Cash / Debt Growth	-16.34%	17.80%	50.95%	1011.04%	-17.53%
Net Cash Per Share	14.20	16.33	13.86	11.82	1.37
Working Capital	434.83	539.77	506.65	393.5	33.36
Book Value Per Share	38.15	42.09	39.40	25.09	4.42

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).